Vanda Pharmaceuticals Inc. Contracts & Agreements

Amendment No. 1 to the Rights Agreement, dated as of May 3, 2024, by and between Vanda Pharmaceuticals Inc. and Equiniti Trust Company, LLC, as rights agent (Filed With SEC on May 3, 2024)

Rights Agreement, dated as of April 17, 2024, by and between Vanda Pharmaceuticals Inc. and Equiniti Trust Company, LLC as rights agent (Filed With SEC on April 17, 2024)

Asset Purchase Agreement, dated December 7, 2023, by and between Actelion Pharmaceuticals Ltd. and the registrant (Filed With SEC on February 8, 2024)

Form of Restricted Stock Unit Award Agreement for U.S. Employees under Amended and Restated 2016 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2023)

Form of Restricted Stock Unit Award Agreement for Senior Management under Amended and Restated 2016 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2023)

Form of Restricted Stock Unit Award Agreement for Outside Directors under Amended and Restated 2016 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2023)

Form of Restricted Stock Unit Award Agreement for UK Employees under the UK Sub Plan under Amended and Restated 2016 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2023)

Form of Notice of Stock Option Grant and Stock Option Agreement for U.S. Employees under Amended and Restated 2016 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2023)

Form of Notice of Stock Option Grant and Stock Option Agreement for Senior Management under Amended and Restated 2016 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2023)

Form of Notice of Stock Option Grant and Stock Option Agreement for Outside Directors under Amended and Restated 2016 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2023)

Form of Notice of Stock Option Grant and Stock Option Agreement for UK Employees under the UK Sub Plan under Amended and Restated 2016 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2023)

Form of Restricted Stock Unit Award Agreement for Executive Officers under the Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on May 3, 2023)

Form of Restricted Stock Unit Award Agreement for Employees under the Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on May 3, 2023)

License Agreement, dated January 13, 2022, by and among MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, Impax Laboratories LLC and the registrant (Filed With SEC on May 6, 2022)

Description of Securities of the registrant (Filed With SEC on February 24, 2022)

Manufacturing Agreement, dated January 24, 2014, by and between Patheon Pharmaceuticals Inc. and the registrant (relating to HETLIOZ (Filed With SEC on February 24, 2022)

Manufacturing Agreement, dated May 6, 2016, by and between Patheon Pharmaceuticals Inc. and the registrant (relating to Fanapt (Filed With SEC on February 24, 2022)

Fifth Amendment to Lease Agreement, dated April 11, 2019 (Filed With SEC on February 11, 2021)

Sixth Amendment to Lease Agreement, dated May 7, 2020, by and between Square 54 Office Owner LLC and the registrant (Filed With SEC on February 11, 2021)

Amended and Restated Employment Agreement, dated July 27, 2020, by and between Kevin Moran and the registrant (Filed With SEC on July 29, 2020)

Amended and Restated Employment Agreement, dated May 5, 2020, by and between Kevin Moran and the registrant (Filed With SEC on May 7, 2020)

Employment Agreement, dated July 3, 2019, by and between Aranthan "AJ" Jones II and the registrant (Filed With SEC on November 7, 2019)

Employment Agreement, dated August 5, 2019, by and between Joakim Wijkstrom and the registrant (Filed With SEC on November 7, 2019)

Employment Agreement, dated August 13, 2018, by and between Timothy Williams and the registrant (Filed With SEC on November 7, 2018)

Amendment to Rights Agreement, dated June 1, 2018, between the Company and American Stock Transfer and Trust Company, as Rights Agent (Filed With SEC on June 1, 2018)

Third Amendment to Lease Agreement, dated March 28, 2018, by and between Square 54 Office Owner LLC and the registrant (Filed With SEC on May 2, 2018)

Fourth Amendment to Lease Agreement, dated March 29, 2018, by and between Square 54 Office Owner LLC and the registrant (Filed With SEC on May 2, 2018)

Amended and Restated Employment Agreement, dated April 30, 2018, by and between Gunther Birznieks and the registrant (Filed With SEC on May 2, 2018)

Underwriting Agreement, dated March 15, 2018 by and among the Company, Citigroup Global Markets Inc. and Jefferies LLC, as representatives of the several underwriters named therein (Filed With SEC on March 16, 2018)

Employment Agreement, dated June 12, 2009, by and between Gunther Birznieks and the registrant (Filed With SEC on February 15, 2018)

CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT (Filed With SEC on February 17, 2017)

Manufacturing Agreement May 6, 2016 Table of Contents (Filed With SEC on July 28, 2016)

AMENDMENT NO. 2 TO LEASE (Filed With SEC on July 28, 2016)

AGREEMENT OF SUBLEASE (Filed With SEC on July 28, 2016)

UK SUB-PLAN TO THE VANDA PHARMACEUTICALS INC. 2006 EQUITY INCENTIVE PLAN (Filed With SEC on February 12, 2016)

UK SUB-PLAN TO THE VANDA PHARMACEUTICALS INC. 2006 EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on February 12, 2016)

UK SUB-PLAN TO THE VANDA PHARMACEUTICALS INC. 2006 EQUITY INCENTIVE PLAN: NOTICE OF RESTRICTED STOCK UNIT AWARD (Filed With SEC on February 12, 2016)

AGREEMENT (Filed With SEC on February 4, 2016)

VANDA PHARMACEUTICALS INC. EMPLOYMENT AGREEMENT (Filed With SEC on November 4, 2015)

VANDA PHARMACEUTICALS INC. EMPLOYMENT AGREEMENT (Filed With SEC on July 31, 2015)

SETTLEMENT AGREEMENT AND MUTUAL GENERAL RELEASE (Filed With SEC on March 13, 2015)

CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 13, 2015)

CONFIDENTIAL TREATMENT REQUESTED AMENDMENT NO. 1 TO SUBLICENSE AGREEMENT (Filed With SEC on March 13, 2015)

CONFIDENTIAL TREATMENT REQUESTED AMENDMENT NO. 2 TO SUBLICENSE AGREEMENT (Filed With SEC on March 13, 2015)

CONFIDENTIAL TREATMENT REQUESTED AMENDMENT NO. 3 TO SUBLICENSE AGREEMENT (Filed With SEC on March 13, 2015)

STOCK PURCHASE AGREEMENT (Filed With SEC on March 13, 2015)

CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 13, 2015)

5,000,000 Shares of Common Stock par value $0.001 750,000 Option Shares Vanda Pharmaceuticals Inc. PURCHASE AGREEMENT (Filed With SEC on October 29, 2014)

CONFIDENTIAL TREATMENT REQUESTED Manufacturing Agreement January 24, 2014 CONFIDENTIAL TREATMENT REQUESTED Table of Contents (Filed With SEC on May 8, 2014)

AMENDMENT NO. 1 TO LEASE (Filed With SEC on May 8, 2014)

VANDA PHARMACEUTICALS INC. December 2, 2013 (Filed With SEC on February 25, 2014)

4,680,000 Shares of Common Stock par value $0.001 702,000 Over-Allotment Shares Vanda Pharmaceuticals Inc. UNDERWRITING AGREEMENT (Filed With SEC on August 7, 2013)

VANDA PHARMACEUTICALS INC. EMPLOYMENT AGREEMENT (Filed With SEC on July 31, 2013)

TENTH AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on April 29, 2013)

VANDA PHARMACEUTICALS INC. September 12, 2012 (Filed With SEC on November 8, 2012)

LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between ELI LILLY AND COMPANY (an Indiana corporation) and VANDA PHARMACEUTICALS INC. (a Delaware corporation) Dated as... (Filed With SEC on August 3, 2012)

NINTH AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on May 30, 2012)

VANDA PHARMACEUTICALS INC. EMPLOYMENT AGREEMENT (Filed With SEC on March 9, 2012)

VANDA PHARMACEUTICALS INC. 2006 EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on March 9, 2012)

VANDA PHARMACEUTICALS INC. 2006 EQUITY INCENTIVE PLAN: NOTICE OF RESTRICTED STOCK UNIT AWARD (Filed With SEC on March 9, 2012)

LEASE BETWEEN SQUARE 54 OFFICE OWNER LLC (as Landlord) AND VANDA PHARMACEUTICALS INC. (as Tenant) 2200 Pennsylvania Avenue, N.W. Washington, D.C. (Filed With SEC on November 7, 2011)

VandaPharmaceuticals Inc. EmploymentAgreement (Filed With SEC on March 10, 2011)

Vanda Pharmaceuticals Inc. (Filed With SEC on March 10, 2011)

TAX INDEMNITY AGREEMENT (Filed With SEC on March 10, 2011)

The election of two directors to serve as Class I directors until the 2013 Annual Meeting of Stockholders (Filed With SEC on June 7, 2010)

AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on April 19, 2010)

AMENDED AND RESTATED (Filed With SEC on March 15, 2010)

AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on December 22, 2009)

Financial Statements (Unaudited) (Filed With SEC on August 10, 2009)

delays in the completion of our clinical trials (Filed With SEC on March 13, 2009)

VANDA PHARMACEUTICALS INC. (Filed With SEC on September 25, 2008)

delays in the completion of our clinical trials (Filed With SEC on March 13, 2008)

FINANCIAL STATEMENTS (UNAUDITED) (Filed With SEC on November 8, 2007)

a failure of our product candidates to be demonstrably safe and effective (Filed With SEC on March 16, 2007)

VANDA PHARMACEUTICALS INC. (Filed With SEC on January 17, 2007)

VANDA PHARMACEUTICALS INC. (Filed With SEC on January 9, 2007)

Vanda Pharmaceuticals Inc. Employment Agreement (Filed With SEC on August 8, 2006)

EX-4.1: 2004 SECURITYHOLDER AGREEMENT (Filed With SEC on April 7, 2006)

EX-10.2: SUBLICENSE AGREEMENT (Filed With SEC on April 7, 2006)

EX-10.3: AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on April 7, 2006)

EX-10.4: NDD-094 LICENSE AGREEMENT (Filed With SEC on April 7, 2006)

EX-1.1: FORM OF UNDERWRITING AGREEMENT (Filed With SEC on March 28, 2006)

EX-10.17: FORM OF INCENTIVE PLAN (Filed With SEC on March 28, 2006)

iloperidone, a compound for the treatment of schizophrenia and bipolar disorder, which we are currently evaluating in a Phase III trial for schizophrenia that we anticipate will... (Filed With SEC on March 17, 2006)

EX-10.2: SUBLICENSE AGREEMET (Filed With SEC on February 16, 2006)

EX-10.3: AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on February 16, 2006)

EX-10.4: NDD-094 LICENSE AGREEMENT (Filed With SEC on February 16, 2006)

EX-4.1: 2004 SECURITYHOLDERS AGREEMENT (Filed With SEC on December 29, 2005)

EX-4.2: CLASS A COMMON STOCK PURCHASE WARRANT (Filed With SEC on December 29, 2005)

EX-4.3: CLASS A COMMON STOCK PURCHASE WARRANT (Filed With SEC on December 29, 2005)

EX-10.1: SECOND AMENDED AND RESTATED MANAGEMENT EQUITY PLAN (Filed With SEC on December 29, 2005)

EX-10.7: LEASE AGREEMENT (Filed With SEC on December 29, 2005)

EX-10.8: AMENDMENT TO LEASE AGREEMENT (Filed With SEC on December 29, 2005)

EX-10.9: LEASE AGREEMENT (Filed With SEC on December 29, 2005)

EX-10.10: SUMMARY PLAN DESCRIPTION PROVIDED FOR THE 401(K) PROFIT SHARING PLAN & TRUST (Filed With SEC on December 29, 2005)

EX-10.11: FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on December 29, 2005)

EX-10.12: EMPLOYMENT AGREEMENT FORM MIHAEL H. POLYMEROPOULOS (Filed With SEC on December 29, 2005)

EX-10.13: EMPLOYMENT AGREEMENT FOR WILLIAM D. CLARK (Filed With SEC on December 29, 2005)

EX-10.14: EMPLOYMENT AGREEMENT FOR STEVE SHALLCROSS (Filed With SEC on December 29, 2005)

EX-10.15: EMPLOYMENT AGREEMENT FOR DEEPAK PHADKE (Filed With SEC on December 29, 2005)

EX-10.16: EMPLOYMENT AGREEMENT FOR THOMAS COPMANN (Filed With SEC on December 29, 2005)

Category

Industry

Companies

Contracts

Vanda Pharmaceuticals Inc. Contracts & Agreements